Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 301 - 310 of 5325 results for "Top 100"

Plenary names new chief executive

KARREN VERGARA  |  MONDAY, 31 MAR 2025
Plenary Group has named its new chief executive as incumbent David Lamming exits the post on July 1. Chief investment officer Paul Crowe takes over the top job. He joined the firm in 2005, involved in structuring and executing most of the major infrastructure ...

Modern family offices want values aligned, pioneer companies

KARREN VERGARA  |  FRIDAY, 28 MAR 2025
Family offices of today are aligning their values and principles across all generations to back pioneer companies that will create deep impact and competitive returns, the recent Impact Investment Summit Asia Pacific heard. Speaking at the two-day event ...

Buyout firm nabs GQG executive

ELIZABETH FRY  |  THURSDAY, 27 MAR 2025
EQT, the Swedish buyout firm, has snapped up GQG Partners' long-serving distribution lead. Daniel Bullock - who worked at GQG for six years - has been appointed EQT's head of private wealth in Australia. Under his leadership, GQG's distribution ...

New gig for JP Morgan's AI guru

ELIZABETH FRY  |  THURSDAY, 27 MAR 2025
Sydney-based Berowne Hlavaty has been appointed global head of applied AI and data science at JP Morgan, the financial services giant. After a long career in quantitative research strategy, Hlavaty is making a switch to an internal technology role where ...

Holding mega-cap stocks could be detrimental: Research

ELIZA BAVIN  |  WEDNESDAY, 26 MAR 2025
The historically high levels of concentration in equity markets of recent years, powered by a handful of mega-caps, points to a likely resurgence of diversified strategies over the next decade, according to new research by Scientific Beta. Scientific ...

Hearts & Minds revalues position amid Opthea fallout

JAMIE WILLIAMSON  |  WEDNESDAY, 26 MAR 2025
Following Regal's lead, Hearts & Minds Investments has now also revalued its holding in Opthea following its failed clinical trials. Yesterday, Regal announced it had significantly devalued its holdings in the biopharmaceutical company after it ...

Regal slashes holdings in Opthea over insolvency concerns

KARREN VERGARA  |  TUESDAY, 25 MAR 2025
Regal Asian Investments (ASX:RG8) has significantly devalued its holdings in biopharmaceutical company Opthea after the latter flagged insolvency concerns amid the failure of a major clinical trial. RG8 has been forced to drop Opthea's value to ...

Sliver of Aussie global equity managers beat index: SPIVA

KARREN VERGARA  |  TUESDAY, 25 MAR 2025
Just 15% of active Australian global equity fund managers outperformed the benchmark, making 2024 one of the worst years for performance, the latest SPIVA Scorecard shows. Last year saw 85% of active global equity funds struggle to keep pace over the ...

State Super: In decline but doing fine

ANDREW MCKEAN  |  FRIDAY, 21 MAR 2025
State Super closed its main defined benefit schemes in 1985 and 1992, meaning the fund is on a long slow march to completion. Its chief executive John Livanas unpacks the challenges of managing a fund with no new members and an inevitable end. State ...

WTW welcomes investment chief

ELIZABETH FRY  |  THURSDAY, 20 MAR 2025
WTW has promoted its deputy chief investment officer to the top investment job, succeeding Craig Baker who is now tasked with pursuing fresh opportunities. Baker, a 30-year veteran of the company, has been appointed chief investment strategist. Baker ...